gemtuzumab ozogamicin
pfizer,ucb pharmaceuticals
['gemtuzumab', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
dr. d hner ( ) presents amlsg 09-09 trial w/ intensive chemo tx w/ randomization to gemtuzumab (go) 3 mg/m2 on d1 of induction 1/2 and consol 1 -&gt; 588 pts with npm1mut aml (median age ~58y; 292 on go arm) -&gt; cr/cri 90 v 86%, 60d mort 6 vs 9% in non-go vs go. #leusm #ash22 
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????